NCT05137080View on ClinicalTrials.gov

Dexamethasone and Functional Outcome After TKA

PHASE4CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

June 7, 2022

Study Completion Date

June 8, 2022

Conditions
Chronic Knee PainDexamethasoneTotal Knee Arthroplasty
Interventions
DRUG

Dexamethasone

24mg dexamethasone

DRUG

Isotonic saline

Isotonic saline

Trial Locations (2)

4200

Næstved, Slagelse and Ringsted Hospitals, Slagelse

4700

Næstved, Slagelse og Ringsted Hospitals, Næstved

All Listed Sponsors
lead

Slagelse Hospital

OTHER

NCT05137080 - Dexamethasone and Functional Outcome After TKA | Biotech Hunter | Biotech Hunter